Teva Pharmaceutical Industries reported $1.9B in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Aerie Pharmaceuticals AERI:US $ 9.28M 1.4M
Amarin AMRN:US $ 116.31M 25.56M
Amgen AMGN:US $ 1256M 147M
Biogen BIIB:US $ 434.8M 36.1M
Bristol Myers Squibb BMY:US $ 2882M 62M
Coherus Biosciences CHRS:US $ 17.49M 3.61M
Eli Lilly And LLY:US $ 1659.3M 226M
Emergent Biosolutions EBS:US $ 106.2M 1.1M
Endo International Ordinary Shares ENDP:US $ 90.64M 10.36M
Henry Schein HSIC:US $ 901M 13M
Horizon Pharma HZNP:US $ 18.54M 48.48M
JAZZ PHA JAZZ:US $ 74.16M 0.82M
Lannett LCI:US $ 29.74M 1.17M
Novartis NOVN:VX 4.97B 114M
Pacira Pharmaceuticals PCRX:US $ 13.98M 0.86M
Patterson Companies PDCO:US $ 655.65M 25.67M
Perrigo Ordinary Shares PRGO:US $ 490.4M 10.8M
Phibro Animal Health PAHC:US $ 95.6M 5.9M
Revance Therapeutics RVNC:US $ 13.27M 3.25M
Takeda 4502:JP Y 424358M 91939M
Teva Pharmaceutical Industries TEVA:US $ 1901M 151M
Xeris Pharmaceuticals Inc XERS:US $ 6.63M 4.46M
Zoetis ZTS:US $ 430M 28M